PSORIASIS-RELATED WORK PRODUCTIVITY IMPROVEMENT FROM A PHASE 4 REAL-WORLD STUDY OF TILDRAKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

被引：0
|
作者：
Bhatia, N. [1 ]
Heim, J. [2 ]
Schenkel, B. [3 ]
Rozzo, S. J. [3 ]
Vasquez, J. G. [2 ]
机构：
[1] Therapeut Clin Res, San Diego, CA USA
[2] West Michigan Dermatol, Grandville, MI USA
[3] Sun Pharmaceut Ind Inc, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR185
引用
收藏
页码：S346 / S347
页数：2
相关论文
共 50 条
  • [1] Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
    Tina Bhutani
    John Koo
    Jayme Heim
    Neal Bhatia
    Jacob Mathew
    Thomas Ferro
    J. Gabriel Vasquez
    [J]. Dermatology and Therapy, 2024, 14 : 1019 - 1025
  • [2] Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
    Bhutani, Tina
    Koo, John
    Heim, Jayme
    Bhatia, Neal
    Mathew, Jacob
    Ferro, Thomas
    Vasquez, J. Gabriel
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (04) : 1019 - 1025
  • [3] PSORIASIS-RELATED WORK PRODUCTIVITY IMPROVEMENT FROM A PHASE 4 REAL-WORLD STUDY INTERIM ANALYSIS OF TILDRAKIZUMAB
    Bhatia, N.
    Heim, J.
    Beute, P.
    Torres, M.
    Schenkel, B.
    Rozzo, S. J.
    Vasquez, J. G.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S390 - S391
  • [4] Safety of tildrakizumab in a Phase 4 real-world study in patients with moderate-to-severe plaque psoriasis
    Vasquez, J. Gabriel
    Bhatia, Neal
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB85 - AB85
  • [5] Real-world effectiveness of tildrakizumab in a Phase 4 study in patients with moderate-to- severe plaque psoriasis
    Bhatia, Neal
    Vasquez, J. Gabriel
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB216 - AB216
  • [6] REAL-WORLD EFFECTIVENESS AND SAFETY IN A PHASE 4 STUDY OF TILDRAKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Bhatia, N.
    Vasquez, J. G.
    Schenkel, B.
    Rozzo, S. J.
    Heim, J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S57 - S57
  • [7] Patients' quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis
    Heim, Jayme
    Vasquez, J. Gabriel
    Rozzo, Stephen J.
    Schenkel, Brad
    Bhatia, Neal
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB204 - AB204
  • [8] Patient satisfaction with tildrakizumab treatment in a Phase 4 real-world study of tildrakizumab in patients with moderate-to-severe psoriasis
    Bhatia, Neal
    Vasquez, J. Gabriel
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB72 - AB72
  • [9] Real-world effectiveness and safety of tildrakizumab in patients with moderate to severe plaque psoriasis: Week 28 interim analysis of a phase 4 study
    Bhatia, Neal
    Heim, Jayme
    Torres, Monique
    Beute, Paulita
    Rozzo, Stephen J.
    Vasquez, J. Gabriel
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB199 - AB199
  • [10] Real-world effectiveness and safety of tildrakizumab in patients with moderate to severe plaque psoriasis: Week 28 interim analysis of a Phase 4 study
    Bhatia, Neal
    Heim, Jayme
    Torres, Monique
    Beute, Paulita
    Rozzo, Stephen J.
    Vasquez, J. Gabriel
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 6 - 7
12345